Skip to main content

Site notifications

Notice for tozinameran and riltozinameran (Pfizer Australia Pty Ltd)

Active ingredients
tozinameran and riltozinameran
Date of review outcome
Lapse date
Type
Provisional determination
Indication
Active immunisation to prevent coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2.

Help us improve the Therapeutic Goods Administration site